{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:08:55Z","timestamp":1790784535389,"version":"4.1.0"},"reference-count":110,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Research in Translational Medicine"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.retram.2023.103425","type":"journal-article","created":{"date-parts":[[2023,10,23]],"date-time":"2023-10-23T15:41:18Z","timestamp":1698075678000},"page":"103425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cytogenetics in the management of mature B-cell non-Hodgkin lymphomas: Guidelines from the Groupe Francophone de Cytog\u00e9n\u00e9tique Hematologique (GFCH)"],"prefix":"10.1016","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0424-3731","authenticated-orcid":false,"given":"C.","family":"Lefebvre","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Veronese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Nadal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-B.","family":"Gaillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Penther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Daudignon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Chauzeix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Nguyen-Khac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Chapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.retram.2023.103425_bib0001","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","article-title":"The 5th edition of the World Health Organization classification of Haematolymphoid tumours: lymphoid neoplasms","volume":"36","author":"Alaggio","year":"2022","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.retram.2023.103425_bib0002","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.retram.2023.103425_bib0003","first-page":"568","article-title":"Cytogenetics in the management of lymphomas and lymphoproliferative disorders in adults and children: an update by the Groupe francophone de cytog\u00e9n\u00e9tique h\u00e9matologique (GFCH)","volume":"74","author":"Lefebvre","year":"2016","journal-title":"Ann Biol Clin (Paris)"},{"issue":"4","key":"10.1016\/j.retram.2023.103425_bib0004","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/gcc.1103","article-title":"Analysis of secondary chromosomal alterations in 165 cases of follicular lymphoma with t(14;18)","volume":"30","author":"Horsman","year":"2001","journal-title":"Genes Chromosomes Cancer"},{"issue":"18","key":"10.1016\/j.retram.2023.103425_bib0005","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1182\/blood-2017-12-820605","article-title":"High-grade B-cell lymphoma with MYC and BCL2 and\/or BCL6 rearrangements with diffuse large B-cell lymphoma morphology","volume":"131","author":"Scott","year":"2018","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.retram.2023.103425_bib0006","first-page":"13","article-title":"Specific chromosomal IG translocations have different prognoses in chronic lymphocytic leukemia","volume":"1","author":"Nguyen-Khac","year":"2011","journal-title":"Am J Blood Res"},{"issue":"2","key":"10.1016\/j.retram.2023.103425_bib0007","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/bjh.17550","article-title":"Adverse outcome in follicular lymphoma is associated with MYC rearrangements but not MYC extra copies","volume":"194","author":"Bussot","year":"2021","journal-title":"Br J Haematol"},{"issue":"22","key":"10.1016\/j.retram.2023.103425_bib0008","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1182\/bloodadvances.2020002944","article-title":"Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease","volume":"4","author":"Nann","year":"2020","journal-title":"Blood Adv"},{"issue":"12","key":"10.1016\/j.retram.2023.103425_bib0009","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1002\/gcc.20606","article-title":"Prognostic significance of secondary cytogenetic alterations in follicular lymphomas","volume":"47","author":"Johnson","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"issue":"1","key":"10.1016\/j.retram.2023.103425_bib0010","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.celrep.2013.12.027","article-title":"Genetics of follicular lymphoma transformation","volume":"6","author":"Pasqualucci","year":"2014","journal-title":"Cell Rep"},{"issue":"4","key":"10.1016\/j.retram.2023.103425_bib0011","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/s41375-020-01014-2","article-title":"Mutation landscape, clonal evolution pattern, and potential pathogenic pathways in B-lymphoblastic transformation of follicular lymphoma","volume":"35","author":"Nie","year":"2021","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.retram.2023.103425_bib0012","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.3324\/haematol.2011.042531","article-title":"Follicular lymphoma grade 3B is a distinct neoplasm according to cytogenetic and immunohistochemical profiles","volume":"96","author":"Horn","year":"2011","journal-title":"Haematologica"},{"issue":"9","key":"10.1016\/j.retram.2023.103425_bib0013","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.3324\/haematol.2021.279351","article-title":"Follicular lymphoma grade 3B and diffuse large B-cell lymphoma present a histopathological and molecular continuum lacking features of progression\/transformation","volume":"107","author":"Koch","year":"2022","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.retram.2023.103425_bib0014","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/modpathol.2016.51","article-title":"Characterization of a variant of t(14;18) negative nodal diffuse follicular lymphoma with CD23 expression, 1p36\/TNFRSF14 abnormalities, and STAT6 mutations","volume":"29","author":"Siddiqi","year":"2016","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.retram.2023.103425_bib0015","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41408-020-0335-0","article-title":"CREBBP and STAT6 co-mutation and 16p13 and 1p36 loss define the t(14;18)-negative diffuse variant of follicular lymphoma","volume":"10","author":"Xian","year":"2020","journal-title":"Blood Cancer J"},{"issue":"8","key":"10.1016\/j.retram.2023.103425_bib0016","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1182\/blood-2016-03-703819","article-title":"Genome-wide analysis of pediatric-type follicular lymphoma reveals low genetic complexity and recurrent alterations of TNFRSF14 gene","volume":"128","author":"Schmidt","year":"2016","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.retram.2023.103425_bib0017","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1080\/10428194.2022.2034158","article-title":"Variant t(11;22)(q13;q11.2) with IGL involvement in mantle cell lymphoma","volume":"63","author":"Cabirta","year":"2022","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1016\/j.retram.2023.103425_bib0018","doi-asserted-by":"crossref","first-page":"e505","DOI":"10.1097\/HS9.0000000000000505","article-title":"CCND1 Genomic Rearrangement as a Secondary Event in High Grade B-Cell Lymphoma","volume":"5","author":"Cheng","year":"2021","journal-title":"Hemasphere"},{"issue":"8","key":"10.1016\/j.retram.2023.103425_bib0019","doi-asserted-by":"crossref","first-page":"e408","DOI":"10.3324\/haematol.2019.237073","article-title":"Cryptic insertions of the immunoglobulin light chain enhancer region near CCND1 in t(11;14)-negative mantle cell lymphoma","volume":"105","author":"Fuster","year":"2020","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.retram.2023.103425_bib0020","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1182\/bloodadvances.2019031450","article-title":"Characterization of a cryptic IGH\/CCND1 rearrangement in a case of mantle cell lymphoma with negative CCND1 FISH studies","volume":"3","author":"Peterson","year":"2019","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.retram.2023.103425_bib0021","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/gcc.22123","article-title":"Complex karyotype in mantle cell lymphoma is a strong prognostic factor for the time to treatment and overall survival, independent of the MCL international prognostic index","volume":"53","author":"Sarkozy","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"issue":"8","key":"10.1016\/j.retram.2023.103425_bib0022","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.3390\/cancers12082120","article-title":"Concurrent TP53 and CDKN2A gene aberrations in newly diagnosed mantle cell lymphoma correlate with chemoresistance and call for innovative upfront therapy","volume":"12","author":"Malarikova","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.retram.2023.103425_bib0023","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1002\/cncr.31328","article-title":"Complex karyotype in patients with mantle cell lymphoma predicts inferior survival and poor response to intensive induction therapy","volume":"124","author":"Greenwell","year":"2018","journal-title":"Cancer"},{"issue":"17","key":"10.1016\/j.retram.2023.103425_bib0024","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood-2017-04-779736","article-title":"TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy","volume":"130","author":"Eskelund","year":"2017","journal-title":"Blood."},{"issue":"5","key":"10.1016\/j.retram.2023.103425_bib0025","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1182\/blood-2015-02-628792","article-title":"High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma","volume":"126","author":"Delfau-Larue","year":"2015","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.retram.2023.103425_bib0026","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1182\/blood-2018-03-838136","article-title":"A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome","volume":"132","author":"Clot","year":"2018","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.retram.2023.103425_bib0027","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.3324\/haematol.2019.243071","article-title":"MYC rearrangement but not extra MYC copies is an independent prognostic factor in patients with mantle cell lymphoma","volume":"106","author":"Wang","year":"2021","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.retram.2023.103425_bib0028","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1182\/blood.2020005289","article-title":"Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes","volume":"136","author":"Nadeu","year":"2020","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.retram.2023.103425_bib0029","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1182\/blood-2012-08-452284","article-title":"CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma","volume":"121","author":"Salaverria","year":"2013","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.retram.2023.103425_bib0030","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1182\/blood-2018-07-862151","article-title":"CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1- mantle cell lymphoma","volume":"133","author":"Mart\u00edn-Garcia","year":"2019","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.retram.2023.103425_bib0031","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1182\/blood.V98.9.2837","article-title":"Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) of mature B-cell malignancies","volume":"98","author":"Sonoki","year":"2001","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.retram.2023.103425_bib0032","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1182\/blood-2002-11-3502","article-title":"Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphoma","volume":"102","author":"Ye","year":"2003","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.retram.2023.103425_bib0033","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1038\/sj.leu.2403501","article-title":"Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites","volume":"18","author":"Streubel","year":"2004","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.retram.2023.103425_bib0034","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/sj.leu.2403644","article-title":"T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma","volume":"19","author":"Streubel","year":"2005","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.retram.2023.103425_bib0035","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1038\/sj.leu.2403909","article-title":"Cytogenetic analysis delineates a spectrum of chromosomal changes that can distinguish non-MALT marginal zone B-cell lymphomas among mature B-cell entities: a description of 103 cases","volume":"19","author":"Callet-Bauchu","year":"2005","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.retram.2023.103425_bib0036","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1182\/blood-2010-02-267476","article-title":"Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group","volume":"116","author":"Salido","year":"2010","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.retram.2023.103425_bib0037","doi-asserted-by":"crossref","first-page":"e44997","DOI":"10.1371\/journal.pone.0044997","article-title":"An integrated genomic and expression analysis of 7q deletion in splenic marginal zone lymphoma","volume":"7","author":"Watkins","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.retram.2023.103425_bib0038","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/bjh.17141","article-title":"Clinical and biological features of B-cell neoplasms with CDK6 translocations: an association with a subgroup of splenic marginal zone lymphomas displaying frequent CD5 expression, prolymphocytic cells, and TP53 abnormalities","volume":"193","author":"Gailllard","year":"2021","journal-title":"Br J Haematol"},{"issue":"Suppl","key":"10.1016\/j.retram.2023.103425_bib0039","first-page":"S38","article-title":"Primary cutaneous marginal zone B-cell lymphoma","volume":"125","author":"Cho-Vega","year":"2006","journal-title":"Am J Clin Pathol"},{"issue":"10","key":"10.1016\/j.retram.2023.103425_bib0040","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1182\/blood-2016-02-696757","article-title":"The genetics of nodal marginal zone lymphoma","volume":"128","author":"Spina","year":"2016","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.retram.2023.103425_bib0041","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1038\/s41375-018-0082-4","article-title":"High-throughput sequencing of nodal marginal zone lymphomas identifies recurrent BRAF mutations","volume":"32","author":"Pillonel","year":"2018","journal-title":"Leukemia"},{"issue":"16","key":"10.1016\/j.retram.2023.103425_bib0042","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1182\/bloodadvances.2022007322","article-title":"A unifying hypothesis for PNMZL and PTFL: morphological variants with a common molecular profile","volume":"6","author":"Salmeron-Villalobos","year":"2022","journal-title":"Blood Adv"},{"issue":"2","key":"10.1016\/j.retram.2023.103425_bib0043","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00428-021-03186-3","article-title":"Mutational landscape of marginal zone B-cell lymphomas of various origin: organotypic alterations and diagnostic potential for assignment of organ origin","volume":"480","author":"Vela","year":"2022","journal-title":"Virchows Arch"},{"issue":"12","key":"10.1016\/j.retram.2023.103425_bib0044","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1182\/blood-2008-12-194852","article-title":"TNFAIP3\/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas","volume":"114","author":"Honma","year":"2009","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.retram.2023.103425_bib0045","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1097\/PAS.0000000000001932","article-title":"Pediatric-type indolent B-cell lymphomas with overlapping clinical, pathologic, and genetic features","volume":"46","author":"Lim","year":"2022","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"10.1016\/j.retram.2023.103425_bib0046","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s00428-023-03493-x","article-title":"Comparison of histological and molecular features of pediatric-type follicular lymphoma and pediatric nodal marginal zone lymphoma","volume":"482","author":"Lee","year":"2023","journal-title":"Virchows Arch"},{"issue":"2","key":"10.1016\/j.retram.2023.103425_bib0047","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/PAS.0000000000000523","article-title":"NOTCH1, TP53, and MAP2K1 mutations in splenic diffuse red pulp small B-cell lymphoma are associated with progressive disease","volume":"40","author":"Martinez","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"10.1016\/j.retram.2023.103425_bib0048","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1182\/blood-2016-11-751024","article-title":"Splenic diffuse red pulp small B-cell lymphoma displays increased expression of cyclin D3 and recurrent CCND3 mutations","volume":"129","author":"Curiel-Olmo","year":"2017","journal-title":"Blood."},{"issue":"1","key":"10.1016\/j.retram.2023.103425_bib0049","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1600-0609.2009.01334.x","article-title":"Characterisation of hairy cell leukaemia by tiling resolution array-based comparative genome hybridisation: a series of 13 cases and review of the literature","volume":"84","author":"Nordgren","year":"2010","journal-title":"Eur J Haematol"},{"issue":"21","key":"10.1016\/j.retram.2023.103425_bib0050","first-page":"1821","article-title":"Genetic characterization of B-cell prolymphocytic leukemia: a prognostic model involving MYC and TP53","volume":"134","author":"Chapiro","year":"2019","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.retram.2023.103425_bib0051","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/s41375-023-01821-3","article-title":"The 5th edition of the WHO classification of haematolymphoid tumors: comments from the Groupe Francophone de Cytog\u00e9n\u00e9tique H\u00e9matologique (GFCH)","volume":"37","author":"Nguyen-Khac","year":"2023","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.retram.2023.103425_bib0052","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/sj.leu.2401644","article-title":"Frequent deletions at 11q23 and 13q14 in B cell prolymphocytic leukemia (B-PLL)","volume":"14","author":"Lens","year":"2000","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.retram.2023.103425_bib0053","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00277-011-1393-y","article-title":"Chronic lymphocytic leukemia and prolymphocytic leukemia with MYC translocations: a subgroup with an aggressive disease course","volume":"91","author":"Put","year":"2012","journal-title":"Ann Hematol"},{"key":"10.1016\/j.retram.2023.103425_bib0054","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.26339","article-title":"Cytogenetic and molecular abnormalities in Waldenstr\u00f6m's macroglobulinemia patients: correlations and prognostic impact","author":"Krzisch","year":"2021","journal-title":"Am J Hematol"},{"issue":"2","key":"10.1016\/j.retram.2023.103425_bib0055","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.clml.2013.02.015","article-title":"Genomic abnormalities of Waldenstr\u00f6m macroglobulinemia and related low-grade B-cell lymphomas","volume":"13","author":"Braggio","year":"2013","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"15","key":"10.1016\/j.retram.2023.103425_bib0056","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1182\/blood-2014-09-602565","article-title":"The cellular origin and malignant transformation of Waldenstr\u00f6m macroglobulinemia","volume":"125","author":"Paiva","year":"2015","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.retram.2023.103425_bib0057","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1038\/sj.leu.2404314","article-title":"Trisomy 4, a new chromosomal abnormality in Waldenstr\u00f6m's macroglobulinemia: a study of 39 cases","volume":"20","author":"Terr\u00e9","year":"2006","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.retram.2023.103425_bib0058","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3324\/haematol.2012.070458","article-title":"Chromosomal aberrations and their prognostic value in a series of 174 untreated patients with Waldenstr\u00f6m's macroglobulinemia","volume":"98","author":"Nguyen-Khac","year":"2013","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.retram.2023.103425_bib0059","first-page":"585","article-title":"Identification of 2 DNA methylation subtypes of Waldenstr\u00f6m macroglobulinemia with plasma and memory B-cell features","volume":"136","author":"Roos-Weil","year":"2020","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.retram.2023.103425_bib0060","doi-asserted-by":"crossref","first-page":"6325","DOI":"10.1158\/1078-0432.CCR-17-0007","article-title":"TP53 mutation and Its prognostic significance in Waldenstrom's Macroglobulinemia","volume":"23","author":"Poulain","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.retram.2023.103425_bib0061","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1158\/2159-8290.CD-18-0873","article-title":"A recurrent activating missense mutation in waldenstr\u00f6m macroglobulinemia affects the DNA binding of the ETS transcription factor SPI1 and enhances proliferation","volume":"9","author":"Roos-Weil","year":"2019","journal-title":"Cancer Discov"},{"issue":"13","key":"10.1016\/j.retram.2023.103425_bib0062","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1182\/blood-2012-09-457101","article-title":"Prevalence and clinical significance of the MYD88 (L265P) somatic mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms","volume":"121","author":"Varettoni","year":"2013","journal-title":"Blood"},{"issue":"1\u20132","key":"10.1016\/j.retram.2023.103425_bib0063","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.beha.2016.08.028","article-title":"Clonal B-cell lymphocytosis of marginal zone origin","volume":"30","author":"Xochelli","year":"2017","journal-title":"Best Pract Res Clin Haematol"},{"issue":"5","key":"10.1016\/j.retram.2023.103425_bib0064","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/bjh.13052","article-title":"Molecular lesions of signalling pathway genes in clonal B-cell lymphocytosis with marginal zone features","volume":"167","author":"Bruscaggin","year":"2014","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.retram.2023.103425_bib0065","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/bjh.13501","article-title":"Sequential karyotyping in Burkitt lymphoma reveals a linear clonal evolution with increase in karyotype complexity and a high frequency of recurrent secondary aberrations","volume":"170","author":"Aukema","year":"2015","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.retram.2023.103425_bib0066","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0263980","article-title":"Cryptic MYC insertions in Burkitt lymphoma: new data and a review of the literature","volume":"17","author":"Woroniecka","year":"2022","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.retram.2023.103425_bib0067","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/leu.2008.281","article-title":"Translocations involving 8q24 in Burkitt lymphoma and other malignant lymphomas: a historical review of cytogenetics in the light of todays knowledge","volume":"23","author":"Boerma","year":"2009","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.retram.2023.103425_bib0068","doi-asserted-by":"crossref","first-page":"e7089","DOI":"10.1371\/journal.pone.0007089","article-title":"High resolution genome-wide analysis of chromosomal alterations in Burkitt's lymphoma","volume":"4","author":"Toujani","year":"2009","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.retram.2023.103425_bib0069","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1182\/blood-2018-09-871418","article-title":"Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma","volume":"133","author":"Grande","year":"2019","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.retram.2023.103425_bib0070","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1182\/blood-2003-05-1545","article-title":"Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray","volume":"103","author":"Hans","year":"2004","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.retram.2023.103425_bib0071","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/(SICI)1098-2264(199906)25:2<123::AID-GCC8>3.0.CO;2-4","article-title":"Cytogenetic analysis of 363 consecutively ascertained diffuse large B-cell lymphomas","volume":"25","author":"Cigudosa","year":"1999","journal-title":"Genes Chromosomes Cancer"},{"issue":"9","key":"10.1016\/j.retram.2023.103425_bib0072","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1182\/blood-2005-04-1399","article-title":"Diffuse large B-cell lymphoma subgroups have distinct genetic profiles that influence tumor biology and improve gene-expression-based survival prediction","volume":"106","author":"Bea","year":"2005","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.retram.2023.103425_bib0073","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.3324\/haematol.2019.223891","article-title":"An increase in MYC copy number has a progressive negative prognostic impact in patients with diffuse large B-cell and high-grade lymphoma, who may benefit from intensified treatment regimens","volume":"105","author":"Schieppati","year":"2020","journal-title":"Haematologica"},{"issue":"35","key":"10.1016\/j.retram.2023.103425_bib0074","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1200\/JCO.19.00743","article-title":"Prognostic significance of MYC rearrangement and translocation partner in diffuse large B-Cell lymphoma: a study by the Lunenburg lymphoma biomarker consortium","volume":"37","author":"Rosenwald","year":"2019","journal-title":"J Clin Oncol"},{"issue":"20","key":"10.1016\/j.retram.2023.103425_bib0075","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1182\/bloodadvances.2018023572","article-title":"High-resolution architecture and partner genes of MYC rearrangements in lymphoma with DLBCL morphology","volume":"2","author":"Chong","year":"2018","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.retram.2023.103425_bib0076","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.patbio.2006.04.001","article-title":"The BCL6 proto-oncogene: a leading role during germinal center development and lymphomagenesis","volume":"55","author":"Jardin","year":"2007","journal-title":"Pathol Biol (Paris)"},{"issue":"8","key":"10.1016\/j.retram.2023.103425_bib0077","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1182\/blood-2010-09-297879","article-title":"Double-hit B-cell lymphomas","volume":"117","author":"Aukema","year":"2011","journal-title":"Blood"},{"issue":"22","key":"10.1016\/j.retram.2023.103425_bib0078","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1182\/blood-2015-05-647602","article-title":"MYC-IG rearrangements are negative predictors of survival in DLBCL patients treated with immunochemotherapy: a GELA\/LYSA study","volume":"126","author":"Copie-Bergman","year":"2015","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.retram.2023.103425_bib0079","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.18632\/oncotarget.6262","article-title":"Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma","volume":"7","author":"Ye","year":"2016","journal-title":"Oncotarget"},{"issue":"21","key":"10.1016\/j.retram.2023.103425_bib0080","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1182\/blood-2017-11-764332","article-title":"Genetics of diffuse large B-cell lymphoma","volume":"131","author":"Pasqualucci","year":"2018","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.retram.2023.103425_bib0081","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/bjh.17811","article-title":"Molecular profiling in diffuse large B-cell lymphoma: why so many types of subtypes?","volume":"196","author":"Morin","year":"2022","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.retram.2023.103425_bib0082","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/s41379-021-00909-4","article-title":"Blastoid high-grade B-cell lymphoma initially presenting in bone marrow: a diagnostic challenge","volume":"35","author":"Khanlari","year":"2022","journal-title":"Mod Pathol"},{"issue":"8","key":"10.1016\/j.retram.2023.103425_bib0083","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.3324\/haematol.2021.279631","article-title":"Mutational landscape of high-grade B-cell lymphoma with MYC-, BCL2 and\/or BCL6 rearrangements characterized by whole-exome sequencing","volume":"107","author":"K\u00fcnstner","year":"2022","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.retram.2023.103425_bib0084","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/s41375-019-0691-6","article-title":"Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC\/BCL2 double-hit","volume":"34","author":"Cucco","year":"2020","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.retram.2023.103425_bib0085","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1182\/blood-2009-03-212191","article-title":"Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival","volume":"114","author":"Johnson","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.retram.2023.103425_bib0086","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.humpath.2018.06.006","article-title":"Lymphomas with pseudo-double-hit BCL6-MYC translocations due to t(3;8)(q27;q24) are associated with a germinal center immunophenotype, extranodal involvement, and frequent BCL2 translocations","volume":"80","author":"Johnson","year":"2018","journal-title":"Hum Pathol"},{"issue":"10","key":"10.1016\/j.retram.2023.103425_bib0087","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1158\/2159-8290.CD-15-0370","article-title":"Detection of enhancer-associated rearrangements reveals mechanisms of oncogene dysregulation in B-cell Lymphoma","volume":"5","author":"Ryan","year":"2015","journal-title":"Cancer Discov"},{"issue":"4","key":"10.1016\/j.retram.2023.103425_bib0088","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3324\/haematol.2013.091827","article-title":"Biological characterization of adult MYC-translocation-positive mature B-cell lymphomas other than molecular Burkitt lymphoma","volume":"99","author":"Aukema","year":"2014","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.retram.2023.103425_bib0089","doi-asserted-by":"crossref","first-page":"e248","DOI":"10.3324\/haematol.2018.207290","article-title":"False-negative rates for MYC fluorescence in situ hybridization probes in B-cell neoplasms","volume":"104","author":"King","year":"2019","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.retram.2023.103425_bib0090","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/bjh.15653","article-title":"Detailed molecular analysis and evaluation of prognosis in cases with high grade B-cell lymphoma with MYC and BCL2 and\/or BCL6 rearrangements","volume":"185","author":"Stengel","year":"2019","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1016\/j.retram.2023.103425_bib0091","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.3324\/haematol.2018.207928","article-title":"Burkitt-like lymphoma with 11q aberration: a germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma","volume":"104","author":"Gonzalez-Farre","year":"2019","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.retram.2023.103425_bib0092","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/bjh.16578","article-title":"Experience with provisional WHO-entities large B-cell lymphoma with IRF4-rearrangement and Burkitt-like lymphoma with 11q aberration in paediatric patients of the NHL-BFM group","volume":"190","author":"Au-Yeung","year":"2020","journal-title":"Br J Haematol"},{"issue":"8","key":"10.1016\/j.retram.2023.103425_bib0093","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1182\/blood-2013-06-507996","article-title":"A recurrent 11q aberration pattern characterizes a subset of MYC-negative high-grade B-cell lymphomas resembling Burkitt lymphoma","volume":"123","author":"Salaverria","year":"2014","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.retram.2023.103425_bib0094","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1182\/blood-2018-07-864025","article-title":"The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma","volume":"133","author":"Wagener","year":"2019","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.retram.2023.103425_bib0095","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/ajcp\/aqx139","article-title":"The 11q-Gain\/Loss Aberration Occurs Recurrently in MYC-Negative Burkitt-like Lymphoma with 11q Aberration, as Well as MYC-Positive Burkitt Lymphoma and MYC-Positive High-Grade B-Cell Lymphoma, NOS","volume":"149","author":"Grygalewicz","year":"2017","journal-title":"Am J Clin Pathol"},{"issue":"23","key":"10.1016\/j.retram.2023.103425_bib0096","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1182\/bloodadvances.2021004635","article-title":"Aggressive B-cell lymphoma cases with 11q aberration patterns indicate a spectrum beyond Burkitt-like lymphoma","volume":"5","author":"Gebauer","year":"2021","journal-title":"Blood Adv"},{"issue":"9","key":"10.1016\/j.retram.2023.103425_bib0097","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1182\/blood.2022018639","article-title":"Extranodal presentation of a MYC\/BCL6 double-hit lymphoma with 11q aberration in an older patient","volume":"141","author":"Lefebvre","year":"2023","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.retram.2023.103425_bib0098","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cancergen.2015.12.005","article-title":"The peculiar 11q-gain\/loss aberration reported in a subset of MYC-negative high-grade B-cell lymphomas can also occur in a MYC-rearranged lymphoma","volume":"209","author":"Havelange","year":"2016","journal-title":"Cancer Genet"},{"issue":"1","key":"10.1016\/j.retram.2023.103425_bib0099","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1182\/blood-2011-01-330795","article-title":"Translocations activating IRF4 identify a subtype of germinal center-derived B-cell lymphoma affecting predominantly children and young adults","volume":"118","author":"Salaverria","year":"2011","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.retram.2023.103425_bib0100","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1182\/bloodadvances.2021006034","article-title":"Diffuse large B-cell lymphomas in adults with aberrant coexpression of CD10, BCL6, and MUM1 are enriched in IRF4 rearrangements","volume":"6","author":"Frauenfeld","year":"2022","journal-title":"Blood Adv"},{"issue":"4","key":"10.1016\/j.retram.2023.103425_bib0101","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1182\/blood.2019002699","article-title":"Distinct molecular profile of IRF4-rearranged large B-cell lymphoma","volume":"135","author":"Ramis-Zaldivar","year":"2020","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.retram.2023.103425_bib0102","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1038\/sj.leu.2404919","article-title":"Further delineation of chromosomal consensus regions in primary mediastinal B-cell lymphomas: an analysis of 37 tumor samples using high-resolution genomic profiling (array-CGH)","volume":"21","author":"Wessendorf","year":"2007","journal-title":"Leukemia"},{"issue":"10","key":"10.1016\/j.retram.2023.103425_bib0103","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/gcc.23069","article-title":"Primary mediastinal large B-cell lymphoma is characterized by large-scale copy-neutral loss of heterozygosity","volume":"61","author":"Tuveri","year":"2022","journal-title":"Genes Chromosomes Cancer"},{"issue":"13","key":"10.1016\/j.retram.2023.103425_bib0104","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1182\/blood-2013-10-535443","article-title":"Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma","volume":"123","author":"Twa","year":"2014","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.retram.2023.103425_bib0105","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/gcc.22345","article-title":"Genomic alterations of the JAK2 and PDL loci occur in a broad spectrum of lymphoid malignancies","volume":"55","author":"Van Roosbroeck","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"issue":"7338","key":"10.1016\/j.retram.2023.103425_bib0106","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nature09754","article-title":"MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers","volume":"471","author":"Steidl","year":"2011","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.retram.2023.103425_bib0107","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.celrep.2015.10.008","article-title":"Genomic alterations in CIITA are frequent in primary mediastinal large B cell lymphoma and are associated with diminished MHC Class II expression","volume":"13","author":"Mottok","year":"2015","journal-title":"Cell Rep"},{"issue":"10","key":"10.1016\/j.retram.2023.103425_bib0108","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1182\/blood.2019001126","article-title":"Integrative genomic analysis identifies key pathogenic mechanisms in primary mediastinal large B-cell lymphoma","volume":"134","author":"Mottok","year":"2019","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.retram.2023.103425_bib0109","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.ajhg.2021.06.001","article-title":"Next-generation cytogenetics: comprehensive assessment of 52 hematological malignancy genomes by optical genome mapping","volume":"108","author":"Neveling","year":"2021","journal-title":"Am J Hum Genet"},{"issue":"12","key":"10.1016\/j.retram.2023.103425_bib0110","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.jmoldx.2022.09.009","article-title":"Clinical validation and diagnostic utility of optical genome mapping for enhanced Cytogenomic analysis of hematological neoplasms","volume":"24","author":"Sahajpal","year":"2022","journal-title":"J Mol Diagn"}],"container-title":["Current Research in Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318623000491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452318623000491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:43:19Z","timestamp":1762821799000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452318623000491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":110,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S2452318623000491"],"URL":"https:\/\/doi.org\/10.1016\/j.retram.2023.103425","relation":{},"ISSN":["2452-3186"],"issn-type":[{"value":"2452-3186","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytogenetics in the management of mature B-cell non-Hodgkin lymphomas: Guidelines from the Groupe Francophone de Cytog\u00e9n\u00e9tique Hematologique (GFCH)","name":"articletitle","label":"Article Title"},{"value":"Current Research in Translational Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.retram.2023.103425","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103425"}}